Hos raske, ældre forsøgspersoner blev valdecoxibs tilsyneladende orale clearance reduceret med en ca.
In healthy elderly subjects, the apparent oral clearance of valdecoxib was reduced, resulting in an approximately 40% higher plasma exposure of valdecoxib